Evidence map›Paper›PMID 30602501›Full record

ArticleInfection and immunity2019

Kei-Ichi Uchiya, Yurie Kamimura, Ayumi Jusakon, Toshiaki Nikai

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 46 citations in OpenAlex.

  1. Design of an oral vaccine againstThe veterinary quarterly · 2026
    Article
  2. Article
  3. Protein-centric mechanisms of typhoidalFrontiers in cellular and infection microbiology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Genome degradation promotesNational science review · 2023
    Article
  13. Article
  14. Molecular Detection of Some Virulence Genes inArchives of Razi Institute · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kei-Ichi UchiyaDepartment of Microbiology, Faculty of Pharmacy, Meijo University, Nagoya, Japan kuchiya@meijo-u.ac.jp.
Yurie KamimuraDepartment of Microbiology, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Ayumi JusakonDepartment of Microbiology, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Toshiaki NikaiDepartment of Microbiology, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Meijo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 1 fimbriae are proteinaceous filamentous structures present on bacterial surfaces and are mainly composed of the major fimbrial protein subunit FimA and the adhesive protein FimH, which is located at the tip of the fimbrial shaft. Here, we investigated the involvement of type 1 fimbriae in the expression of proinflammatory cytokines in macrophages infected with

Indexed as

Salmonella typhimuriumAdhesins, BacterialAnimalsCell LineCytokinesFimbriae ProteinsGene Expression RegulationHumansMacrophagesMiceMutationRNA, MessengerAdhesins, BacterialCytokinesFimbriae ProteinsRNA, MessengerFimHproinflammatory cytokinesSalmonella enterica serovar TyphimuriumToll-like receptor 4type 1 fimbriae

Identifiers

PMID30602501
PMCPMC6386536
OpenAlexW2907341153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.